ABSTRACT: Strain is eliminated as a factor in hydrolysis of the scissile peptide bond by human immunodeficiency virus (HIV)-1 and simian immunodeficiency virus (SIV), based on the first eight complexes of products of hydrolysis with the enzymes. The carboxyl group generated at the scissile bond interacts with both catalytic aspartic acids. The structures directly suggest the interactions of the gemdiol intermediate with the active site. Based on the structures, the nucleophilic water is displaced stereospecifically by substrate binding toward one catalytic aspartic acid, while the scissile carbonyl becomes hydrogen bonded to the other catalytic aspartic acid in position for hydrolysis. Crystal structures for two N-terminal (P) products and ...
The structure of a crystal complex of the chemically synthesized protease of human immunodeficiency ...
The crystal structure of an actual HIV-1 protease-substrate complex is presented at 2.0 A resolution...
The murine monoclonal antibody 1696, produced by immunisation with the HIV-1 protease,inhibits the c...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
The homodimeric HIV-1 protease is the target of some of the most effective antiviral AIDS therapy, a...
It is known that HIV-1 protease is an important target for design of antiviral compounds in the trea...
It is known that HIV-1 protease is an important target for design of antiviral compounds in the trea...
BACKGROUND: It is known that HIV-1 protease is an important target for design of antiviral compounds...
Snapshots of three consecutive steps in the proteolytic reaction of HIV-1 protease (PR) were obtaine...
The structure of a complex between a peptide inhibitor with the sequence N-aceti-Thr-Ile-Nle-t[CH2-N...
The rational design of drugs that can inhibit the action of viral proteases depends on obtaining acc...
Strong hydrogen-bonding forces between the Thr26 and Thr26' of the protease stabilize the internal c...
The structure of a crystal complex of the chemically synthesized protease of human immunodeficiency ...
The structure of a crystal complex of the chemically synthesized protease of human immunodeficiency ...
The crystal structure of an actual HIV-1 protease-substrate complex is presented at 2.0 A resolution...
The murine monoclonal antibody 1696, produced by immunisation with the HIV-1 protease,inhibits the c...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
The homodimeric HIV-1 protease is the target of some of the most effective antiviral AIDS therapy, a...
It is known that HIV-1 protease is an important target for design of antiviral compounds in the trea...
It is known that HIV-1 protease is an important target for design of antiviral compounds in the trea...
BACKGROUND: It is known that HIV-1 protease is an important target for design of antiviral compounds...
Snapshots of three consecutive steps in the proteolytic reaction of HIV-1 protease (PR) were obtaine...
The structure of a complex between a peptide inhibitor with the sequence N-aceti-Thr-Ile-Nle-t[CH2-N...
The rational design of drugs that can inhibit the action of viral proteases depends on obtaining acc...
Strong hydrogen-bonding forces between the Thr26 and Thr26' of the protease stabilize the internal c...
The structure of a crystal complex of the chemically synthesized protease of human immunodeficiency ...
The structure of a crystal complex of the chemically synthesized protease of human immunodeficiency ...
The crystal structure of an actual HIV-1 protease-substrate complex is presented at 2.0 A resolution...
The murine monoclonal antibody 1696, produced by immunisation with the HIV-1 protease,inhibits the c...